BackZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Overview

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) Operating Income

Track ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s operating income ($-25B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1304698000.00
↓ 39.16% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-24652817000.00
↑ 457.98% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) (LSPRU) FAQ

As of the most recent data (March 2026), LSPRU shows a operating income of $-25B. That compares with $-4.4B in the prior-year period — down 458.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSPRU's operating income is now $-25B (was $-4.4B) — a 458.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) is outperforming or lagging.

Tracking LSPRU's operating income over time shows whether ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $-25B That compares with $-4.4B in the prior-year period — down 458.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-25B) with ownership activity and broader fundamentals.